Free shipping on all orders over $ 500

KHK-IN-1 hydrochloride 

Cat. No. M28139

All AbMole products are for research use only, cannot be used for human consumption.

KHK-IN-1 hydrochloride  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

KHK-IN-1 hydrochloride (compound 8) is a selective and cell membrane permeable ketohexokinase (KHK) inhibitor (IC50=12 nM; F=34%). KHK-IN-1 hydrochloride inhibits the production of F1P in HepG2 cell lysates (IC>sub>50=400 nM). KHK-IN-1 hydrochloride has potential for the study of diabetes and obesity.

Chemical Information
Molecular Weight 459.01
Formula C21H27ClN8S
CAS Number 1303470-48-5
Form Solid
Solubility (25°C) DMSO 25 mg/mL (ultrasonic)
Water 14.29 mg/mL (ultrasonic and warming and heat to 60°C)
Storage -20°C, dry, sealed
References

[1] Ha Jung Lee, et al. Cells. Nalfurafine Hydrochloride, a κ-Opioid Receptor Agonist, Induces Melanophagy via PKA Inhibition in B16F1 Cells

[2] No authors listed. Carteolol

[3] Mari Amino, et al. J Cardiovasc Pharmacol. Nifekalant Hydrochloride and Amiodarone Hydrochloride Result in Similar Improvements for 24-Hour Survival in Cardiopulmonary Arrest Patients: The SOS-KANTO 2012 Study

[4] Ji-Tai Li, et al. Ultrason Sonochem. Synthesis of 2-(1,5-diaryl-1,4-pentadien-3-ylidene)-hydrazinecarboximidamide hydrochloride catalyzed by p-dodecylbenzenesulfonic acid in aqueous media under ultrasound irradiation

[5] S Groszkowski, et al. Pol J Pharmacol Pharm. 1-Haloacylpiperazines

Related Ketohexokinase Products
KHK-IN-3

KHK-IN-3 is a ketohexokinase (KHK) inhibitor.

KHK-IN-2 

KHK-IN-2 is a potent and selective ketohexokinase (KHK) inhibitor with an IC50 of 0.45 μM.

KHK-IN-1 

KHK-IN-1 (compound 8) is a selective and cell membrane permeable ketohexokinase (KHK) inhibitor (IC50=12 nM; F=34%). KHK-IN-1 inhibits the production of F1P in HepG2 cell lysates (IC>sub>50=400 nM). KHK-IN-1 has potential for the study of diabetes and obesity.

PF-06835919

PF-06835919 is an oral Class I clinical candidate for NAFLD/NASH, targeting ketohexokinase (KHK), an enzyme that initiates fructose metabolism.

  Catalog
Abmole Inhibitor Catalog




Keywords: KHK-IN-1 hydrochloride  supplier, Ketohexokinase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.